iHuman Inc. (IH)
NYSE: IH · Real-Time Price · USD
1.770
-0.012 (-0.67%)
Nov 4, 2024, 3:59 PM EST - Market closed

iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $92.70 million. The enterprise value is -$61.70 million.

Market Cap 92.70M
Enterprise Value -61.70M

Important Dates

The next estimated earnings date is Thursday, December 26, 2024, before market open.

Earnings Date Dec 26, 2024
Ex-Dividend Date n/a

Share Statistics

iHuman has 52.37 million shares outstanding. The number of shares has increased by 0.40% in one year.

Shares Outstanding 52.37M
Shares Change (YoY) +0.40%
Shares Change (QoQ) -0.72%
Owned by Insiders (%) 70.27%
Owned by Institutions (%) 0.39%
Float 15.57M

Valuation Ratios

The trailing PE ratio is 5.39.

PE Ratio 5.39
Forward PE n/a
PS Ratio 0.71
Forward PS n/a
PB Ratio 0.75
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.00.

Current Ratio 2.89
Quick Ratio 2.64
Debt / Equity 0.00
Debt / EBITDA 0.02
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 14.79% and return on invested capital (ROIC) is 6.87%.

Return on Equity (ROE) 14.79%
Return on Assets (ROA) 4.56%
Return on Capital (ROIC) 6.87%
Revenue Per Employee $169,078
Profits Per Employee $23,225
Employee Count 783
Asset Turnover 0.71
Inventory Turnover 16.21

Taxes

In the past 12 months, iHuman has paid $1.83 million in taxes.

Income Tax 1.83M
Effective Tax Rate 9.16%

Stock Price Statistics

The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.47, so iHuman's price volatility has been lower than the market average.

Beta (5Y) 0.47
52-Week Price Change -40.00%
50-Day Moving Average 1.79
200-Day Moving Average 1.87
Relative Strength Index (RSI) 44.08
Average Volume (20 Days) 18,025

Short Selling Information

Short Interest 7,462
Short Previous Month 1,129
Short % of Shares Out 0.04%
Short % of Float n/a
Short Ratio (days to cover) 0.23

Income Statement

In the last 12 months, iHuman had revenue of $132.39 million and earned $18.19 million in profits. Earnings per share was $0.33.

Revenue 132.39M
Gross Profit 94.22M
Operating Income 13.57M
Pretax Income 23.18M
Net Income 18.19M
EBITDA 15.23M
EBIT 13.57M
Earnings Per Share (EPS) $0.33
Full Income Statement

Balance Sheet

The company has $155.42 million in cash and $395,079 in debt, giving a net cash position of $155.02 million or $2.96 per share.

Cash & Cash Equivalents 155.42M
Total Debt 395,079
Net Cash 155.02M
Net Cash Per Share $2.96
Equity (Book Value) 125.10M
Book Value Per Share 2.39
Working Capital 116.69M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 71.17%, with operating and profit margins of 10.25% and 13.74%.

Gross Margin 71.17%
Operating Margin 10.25%
Pretax Margin 15.12%
Profit Margin 13.74%
EBITDA Margin 11.51%
EBIT Margin 10.25%
FCF Margin n/a

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.40%
Shareholder Yield -0.40%
Earnings Yield 19.49%
FCF Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

iHuman has an Altman Z-Score of 2.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.88
Piotroski F-Score 4